Indication
Trichotillomania
8 clinical trials
6 products
2 drugs
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study to Assess the Safety, Tolerability, and Efficacy of Valbenazine for the Treatment of Trichotillomania in AdultsStatus: Recruiting, Estimated PCD: 2025-10-15
Product
ValbenazineClinical trial
Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive BehaviorsStatus: Recruiting, Estimated PCD: 2024-06-01
Product
MemantineClinical trial
An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept StudyStatus: Recruiting, Estimated PCD: 2024-09-01
Drug
cannabidiolClinical trial
A Double-Blind, Placebo-Controlled Study of Memantine in Body Focused Repetitive BehaviorsStatus: Completed, Estimated PCD: 2022-07-08
Drug
VarlilumabClinical trial
An Open-Label Study of Dronabinol, a Cannabinoid Agonist, for Obsessive Compulsive Disorder and the Obsessive-Compulsive Spectrum Disorders Trichotillomania and Pathological Skin PickingStatus: Completed, Estimated PCD: 2011-01-01
Product
DronabinolClinical trial
A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive BehaviorsStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Product
AripiprazoleClinical trial
A Double-Blind, Placebo-Controlled Study of Inositol in TrichotillomaniaStatus: Completed, Estimated PCD: 2016-05-01
Product
InositolClinical trial
A Double-Blind, Placebo-Controlled Study of N-Acetyl Cysteine in TrichotillomaniaStatus: Completed, Estimated PCD: 2008-09-01
Product
N-Acetyl Cysteine